Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

von Loeffelholz, Christian; Gissey, Lidia Castagneto; Schumann, Tina; Henke, Christine; Kurzbach, Anica; Struck, Joachim; Bergmann, Andreas; Hanefeld, Markolf; Schatz, Ulrike; Bornstein, Stefan R; Casella, Giovanni; Mingrone, Geltrude; Birkenfeld, Andreas L (2018). The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery. International Journal of Obesity, 42(12):2057-2061.

Schindler, Christoph; Birkenfeld, Andreas L; Hanefeld, Markolf; Schatz, Ulrike; Köhler, Carsta; Grüneberg, Martin; Tschöpe, Diethelm; Blüher, Matthias; Hasslacher, Christoph; Bornstein, Stefan R (2018). Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes Therapy, 9(1):37-47.

Gilbert, Richard E; Mann, Johannes F E; Hanefeld, Markolf; Spinas, Giatgen; Bosch, Jackie; Yusuf, Salim; Gerstein, Hertzel C (2014). Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: Results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial. Diabetologia, 57(7):1325-1331.

Riddle, Matthew C; Gerstein, Hertzel C; Dyal, Leanne; Hanefeld, Markolf; Johnston, Peter; Probstfield, Jeffrey; Ramachandran, Ambady; Rosenstock, Julio; Rydén, Lars E; Spinas, Giagten A (2013). Characteristics associated with maintenance of mean A1C<6.5% in people with dysglycemia in the ORIGIN trial. Diabetes Care, 36(10):2915-2922.

This list was generated on Wed Aug 21 11:14:31 2019 CEST.